In other recent news, 22nd Century Group reported its financial results for the fourth quarter of 2024, revealing a decline in net revenue to $4 million from $5.9 million in the previous quarter.

22nd Century Group, Inc. (NASDAQ:XXII – Get Free Report) saw a large decline in short interest in March.As of March 31st, there was short interest totalling 18,900 shares, a decline of 70.8% ...

MOCKSVILLE, N.C. - 22nd Century Group, Inc. (NASDAQ:XXII), a company specializing in tobacco products with reduced nicotine content, has announced new agreements to supply filtered cigars ...

MOCKSVILLE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine by offering smokers a choice ...

22nd Century Group shares are trading lower by 45% to $1.96 during Monday's session. The stock is potentially trading lower likely due to profit-taking following a new contract manufacturing ...

22nd Century Group is exiting the hemp/ cannabis sector after less than 1½ years at a steep financial cost. The manufacturer, who is based in New York but has significant operations in Mocksville ...

22nd Century Group will sell its cannabis and hemp business, and has named a new chairman and CEO. The Buffalo-based plant biotechnology company has agreed to sell GVB Biopharma to Nevada-based ...

In conjunction with the deal, CORE Senior Partner Frank Papa will become chairman of Century Box’s board of directors Winston & Strawn LLP provided legal representation to CORE in the ...

22nd Century Group has made a change at CEO, completed a stock sale and launched a cost-cutting effort. John Miller was named interim CEO of the Buffalo-based plant technology company. James A.

BUFFALO, N.Y., April 05, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp ...